op 2507 has been researched along with 6-ketoprostaglandin f1 alpha in 5 studies
Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
33 | 0 | 1 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwata, M | 1 |
Ishii, T; Kai, T; Kamada, N; Kim, YI; Kitano, S; Sugimachi, K; Tatsuma, T | 1 |
Iida, T; Kawarada, Y; Yokoi, H | 1 |
Arima, T; Hirano, T; Kawano, R; Motoyama, K; Nakafusa, Y; Sugitani, A; Tanaka, M | 1 |
Kawamoto, T; Kurata, M; Ohkohchi, N; Okajima, K; Uchiba, M | 1 |
5 other study(ies) available for op 2507 and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cause of Death; Dogs; Epoprostenol; Female; Hepatectomy; Histamine Antagonists; Hyaluronic Acid; Liver; Liver Function Tests; Male; Methacrylates; Prostaglandins; Radioimmunoassay; Survival Rate; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1994 |
Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspartate Aminotransferases; Cryoprotective Agents; Dinoprostone; Endotoxins; Epoprostenol; Female; Ischemia; Liver; Prostaglandins; Swine; Thromboxane B2 | 1994 |
The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Epoprostenol; Injections, Subcutaneous; Kidney; Lung; Male; Methacrylates; Pancreas; Pancreatitis, Acute Necrotizing; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1998 |
The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteriosclerosis; Cell Nucleus; Drug Therapy, Combination; Enzyme Inhibitors; Epoprostenol; Kinetics; Male; Methacrylates; Rats; Rats, Inbred Lew; Rats, Wistar; Superoxides; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Homologous | 2001 |
Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antithrombins; Arginine; Cell Line, Tumor; Colonic Neoplasms; E-Selectin; Epoprostenol; Fibrin Fibrinogen Degradation Products; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Pipecolic Acids; Rats; Rats, Inbred F344; Reperfusion; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha | 2006 |